| __timestamp | Bristol-Myers Squibb Company | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 11947000000 | 52602000 |
| Thursday, January 1, 2015 | 12651000000 | 105812000 |
| Friday, January 1, 2016 | 14481000000 | 113485000 |
| Sunday, January 1, 2017 | 14710000000 | 285461000 |
| Monday, January 1, 2018 | 16014000000 | 141726000 |
| Tuesday, January 1, 2019 | 18067000000 | 150446000 |
| Wednesday, January 1, 2020 | 30745000000 | 224227000 |
| Friday, January 1, 2021 | 36445000000 | 361897000 |
| Saturday, January 1, 2022 | 36022000000 | 520812000 |
| Sunday, January 1, 2023 | 34313000000 | 636892000 |
| Monday, January 1, 2024 | 36351000000 | 855907000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical industry, Bristol-Myers Squibb Company and Halozyme Therapeutics, Inc. present a fascinating study in contrasts. Over the past decade, Bristol-Myers Squibb has demonstrated a robust growth trajectory, with its gross profit surging by nearly 187% from 2014 to 2023. This growth is particularly notable in 2020, where the company saw a significant leap, likely driven by strategic acquisitions and product innovations.
Conversely, Halozyme Therapeutics, Inc., while smaller in scale, has shown a steady upward trend, with its gross profit increasing by over 1,100% during the same period. This remarkable growth, albeit from a smaller base, underscores Halozyme's potential in niche markets and innovative drug delivery solutions.
These trends highlight the diverse strategies and market positions of these two companies, offering valuable insights into their future trajectories.
Who Generates Higher Gross Profit? Novartis AG or Bristol-Myers Squibb Company
Gross Profit Trends Compared: Amgen Inc. vs Halozyme Therapeutics, Inc.
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Genmab A/S
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Viatris Inc.
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs HUTCHMED (China) Limited
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Perrigo Company plc Trends
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Evotec SE Trends
Halozyme Therapeutics, Inc. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis